Skip to main content
Clinical Trials/IRCT20231217060445N1
IRCT20231217060445N1RecruitingPhase 3

Comparison of the effect of low and normal levels of sodium in the dialysis fluid on the levels of calcium, phosphorus and parathyroid hormone in patients undergoing chronic hemodialysis

Ahvaz University of Medical Sciences0 sites80 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 3
Status
Recruiting
Enrollment
80

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 years to 60 years (—)
Sex
All

Inclusion Criteria

  • Chronic hemodialysis patients aged 18 to 60 years

Exclusion Criteria

  • The presence of any uncontrolled underlying disease (such as pheochromocytoma or other cardio-pulmonary and liver diseases)
  • Presence of active infection
  • Occurrence of frequent muscle cramps that cannot be found due to low sodium.
  • Patient's sodium is less than 130 mEq/L
  • Systolic or diastolic blood pressure drop of more than 20 mm Hg compared to the patient's baseline pressure.

Investigators

Similar Trials